Preventive Effects of Synbiotic Oral Supplementation on Infant Colic: A Prospective Randomized Clinical Trial Study
Archives of Pediatric Infectious Diseases · 09.02.2026 · 14 (4)
DOI: 10.5812/apid-167035 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Pediatric Infectious Diseases, online erschienen am 09.02.2026. Verfasst von Fatemeh-Sadat Fahimzad und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Infantile colic (IC) is a common functional gastrointestinal (GI) disorder that significantly affects infants and their families. Recent evidence suggests that modulation of gut microbiota through synbiotic supplementation may alleviate colic symptoms.
Objectives
This study aimed to survey two parallel-groups clinical trial was therefore designed to evaluate the preventive effects of synbiotic supplementation on the incidence of infant colic, maternal quality of life, and infant fecal calprotectin levels.
Methods
In a triple-blind, randomized, placebo-controlled trial, 104 healthy full-term infants aged < 10 days, and without antibiotic exposure were assigned to receive either 10 drops of a synbiotic supplement or placebo daily for 8 weeks. Outcomes included incidence of colic, maternal quality of life [short form health survey (36 items; SF-36)], fecal calprotectin levels, and infant colic behaviors, recorded using a validated Barr diary.
Results
A total of 83 infants completed the study (Synbiotic group = 39, Placebo group = 44). A clinically meaningful reduction in the incidence of colic (15.4% synbiotic group, 29.5% placebo group) and maternal pain was seen in the synbiotic group (P = 0.04). Fecal calprotectin levels, crying duration, and restlessness decreased in both groups, but between-group differences were not statistically significant. No effect was found on infant growth parameters.
Conclusions
Preventive synbiotic supplementation may have beneficial clinical effects on reducing colic incidence and improving maternal comfort, though larger studies are needed to confirm these findings and explore underlying mechanisms.
Zitieren
APA
Fahimzad, F., Hosseinzadeh-Attar, M. J., Azimi, L., Asghari, S., Shamshiri, A. R., Fahimzad, A., & Koujan, S. E. (2026). Preventive Effects of Synbiotic Oral Supplementation on Infant Colic: A Prospective Randomized Clinical Trial Study. Archives of Pediatric Infectious Diseases, 14(4). https://doi.org/10.5812/apid-167035
Vancouver
Fahimzad F, Hosseinzadeh-Attar MJ, Azimi L, Asghari S, Shamshiri AR, Fahimzad A, et al. Preventive Effects of Synbiotic Oral Supplementation on Infant Colic: A Prospective Randomized Clinical Trial Study. Archives of Pediatric Infectious Diseases. 2026;14(4). doi:10.5812/apid-167035
BibTeX
@article{Fahimzad2026,
author = {Fahimzad, Fatemeh-Sadat and Hosseinzadeh-Attar, Mohammad Javad and Azimi, Leila and Asghari, Somayyeh and Shamshiri, Ahmad Reza and Fahimzad, Alireza and Koujan, Soraya Ebrahimpour},
title = {Preventive Effects of Synbiotic Oral Supplementation on Infant Colic: A Prospective Randomized Clinical Trial Study},
journal = {Archives of Pediatric Infectious Diseases},
year = {2026},
volume = {14},
number = {4},
doi = {10.5812/apid-167035}
}
EUVIMED